Elanco Animal Health to acquire Aratana TherapeuticsApril 30, 2019Elanco Animal Health has signed an agreement to acquire Aratana Therapeutics. The deal allows Elanco to integrate the Aratana portfolio of pet therapeutics into its companion animal therapeutics business. "Aratana has been one of the most innovative start-ups in animal health, bringing breakthrough solutions to the market," says Elanco president and chief executive officer, Jeff Simmons. "We look forward to putting greater energy behind these brands with our increased share of voice in the …
SPONSORED CONTENTHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More